Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-041639

President and CEO acquired 814 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2022-06-30 Grant or award +814 $14.24 $11,591 254,554 D
Loading xslF345X03/doc4.xml…